MarketCapTrends
RMD

ResMed Inc. (RMD)

NYSE · Healthcare

ResMed Inc. annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • ResMed Inc. shareholder equity for the quarter ending June 30, 2025 were 5.97B, a 22.69% increase year-over-year.
  • ResMed Inc. shareholder equity for 2025 were 5.97B, a 22.69% increase from 2024.
  • ResMed Inc. shareholder equity for 2024 were 4.86B, a 17.78% increase from 2023.
  • ResMed Inc. shareholder equity for 2023 were 4.13B, a 22.89% increase from 2022.
  • ResMed Inc. shareholder equity for 2022 were 3.36B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
ResMed Inc. Annual Shareholder Equity (Millions of US $)
2025$5,968
2024$4,864
2023$4,130
2022$3,361
2021$2,886
2020$2,497
2019$2,072
2018$2,059
2017$1,960
2016$1,695
2015$1,587
2014$1,758
2013$1,611
2012$1,608
2011$1,731
ResMed Inc. Quarterly Shareholder Equity (Millions of US $)
2025-06-30$5,968
2024-06-30$4,864
2023-06-30$4,130
2022-06-30$3,361
2021-06-30$2,886
2020-06-30$2,497
2019-06-30$2,072
2018-06-30$2,059
2017-06-30$1,960
2016-06-30$1,695
2015-06-30$1,587
2014-06-30$1,758
2013-06-30$1,611
2012-06-30$1,608
2011-06-30$1,731
2010-06-30$1,288

ResMed Inc. Shareholder Equity — FAQ

ResMed Inc. (RMD) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RMD's shareholder equity history?

The chart and table above show ResMed Inc.'s shareholder equity by year and by quarter, including the growth rate.